TB

This toolbox provides tools and guides for developing and implementing TB trainings for clinicians and other health workers. It describes how to develop timelines for trainings; conduct needs assessments to determine training needs; create agendas, syllabi, slides, and other course materials; handle training logistics and faculty recruitment; and issue CE or CME units to course participants. It includes sample correspondence, agendas, and timelines; slide templates; and course outlines.

This 5-part video (50 min) presentation is designed for clinicians who diagnose and treat tuberculosis and latent tuberculosis infection in children. The course provides a thorough clinical overview of pediatric TB and includes supplemental resource materials.

Extensively drug-resistant tuberculosis (XDR TB) outbreaks have been reported in South Africa, and strains have been identified on 6 continents. Dr. Peter Cegielski, team leader for drug-resistant TB with the Division of Tuberculosis Elimination at CDC, comments on a multinational team's report on this emerging global public health threat.

This fact sheet includes helpful hints on pediatric medicine administration if a child has difficulty swallowing pills or capsules.

This fact sheet explains the facts about DOT.

This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.

This pamphlet uses a question and answer format to provide information on the bacille Calmette-Guerin (BCG) vaccine for TB. It discusses skin test results in relation to the BCG vaccine and treatment.

In recognition of the worldwide TB epidemic, this useful publication has been extensively updated. The comprehensive and easily readable text covers the clinician’s and patient’s perspective; practical information including the DOT strategy for adherence to treatment; treatment and management.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.